Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...
Huvudupphovsmän: | Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Oxford University Press
2019
|
Liknande verk
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
av: Wang, Y, et al.
Publicerad: (2020) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
av: Parvaiz A Koul, et al.
Publicerad: (2024-01-01) -
Does Oseltamivir Really Reduce Complications of Influenza?
av: Del Mar, C, et al.
Publicerad: (2011) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
av: Chairat, K, et al.
Publicerad: (2016) -
Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
av: Mihai Maria Elena, et al.
Publicerad: (2024-04-01)